Regulatory RNA-based
interactions are critical for coordinating
gene expression and are increasingly being targeted in synthetic biology,
antimicrobial, and therapeutic fields. Bacterial trans-encoded small RNAs (sRNAs) regulate the translation and/or stability
of mRNA targets through base-pairing interactions. These interactions
are often integral to complex gene circuits which coordinate critical
bacterial processes. The ability to predictably modulate these gene
circuits has potential for reprogramming gene expression for synthetic
biology and antibacterial purposes. Here, we present a novel pipeline
for targeting such RNA-based interactions with antisense oligonucleotides
(ASOs) in order to reprogram gene expression. As proof-of-concept,
we selected sRNA–mRNA interactions that are central to the Vibrio cholerae quorum sensing pathway, required for V. cholerae pathogenesis, as a regulatory RNA-based interaction
input. We rationally designed anti-sRNA ASOs to target the sRNAs and
synthesized them as peptide nucleic acids (PNAs). Next, we devised
an RNA array-based interaction assay to allow screening of the anti-sRNA
ASOs in vitro. Finally, an Escherichia coli-based gene expression reporter assay was developed and used to validate
anti-sRNA ASO regulatory activity in a cellular environment. The output
from the pipeline was an anti-sRNA ASO that targets sRNAs to inhibit
sRNA–mRNA interactions and modulate gene expression. This anti-sRNA
ASO has potential for reprogramming gene expression for synthetic
biology and/or antibacterial purposes. We anticipate that this pipeline
will find widespread use in fields targeting RNA-based interactions
as modulators of gene expression.